© 2004 by Oxford University Press
© 2004 Oxford University Press
ARTICLE |
Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
Affiliation of authors: Division of Surgical Oncology and School of Public Health, University of Minnesota, Minneapolis
Correspondence to: Nancy Baxter, MD, PhD, MMC 450, Department of Surgery, University of Minnesota, 420 Delaware St. SE, Minneapolis, MN 55455 (e-mail: baxte025{at}umn.edu)
Background: An increase in incidence of ductal carcinoma in situ (DCIS) of the breast has been documented, and concerns regarding overly aggressive treatment have been raised. This study was designed to evaluate the use of surgery and radiation therapy in treating DCIS. Methods: We used the National Cancer Institute’s Surveillance, Epidemiology, and End Results database to assess treatment of patients with DCIS with no evidence of microinvasion who were diagnosed from January 1, 1992, through December 31, 1999. We assessed the rates of mastectomy, breast reconstruction, radiation therapy after lumpectomy, and axillary dissection. Associations were analyzed by logistic regression. Results: During the study period, 25 206 patients met selection criteria. The incidence of DCIS dramatically increased with time; however, the incidence of comedo lesions did not change. The rate of mastectomy decreased from 43% in 1992 to 28% in 1999, after controlling for age, race, tumor size, comedo histology, and geographic location. However, because of the increase in the diagnosis of DCIS, the age-adjusted incidence of mastectomy for DCIS in the population did not change (7.8 per 100 000 women in 1992 and 1999). Almost half the patients undergoing lumpectomy did not undergo radiation therapy (55% in 1992 and 46% in 1999); in those with comedo histology, 33% did not undergo radiation therapy after lumpectomy, even in 1999. Overall, patients were less likely to have axillary dissection over time (34% in 1992 versus 15% in 1999), yet the rate of axillary dissection was still high (30%) in patients undergoing mastectomy in 1999. Large, statistically and clinically significant variation by geographic location was found in treatment. Conclusions: Treatment of DCIS changed in a clinically significant fashion between 1992 and 1999. Throughout this study, many patients were found to undergo aggressive surgical therapy, including mastectomy and axillary dissection, whereas others appeared to be undertreated, e.g., not receiving radiation therapy after lumpectomy, even in the presence of adverse histologic features. Variation in demographic and geographic factors indicates that at least some of these treatment differences reflect individual and institutional practice patterns that may be modifiable.
CiteULike 
Connotea 
Del.icio.us What's this?
Correspondence about this Article
- Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
- Heather Taffet Gold and Andrew W. Dick
J Natl Cancer Inst 2004 96: 887-888.[Extract] [Full Text] [PDF]
- Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
- Mattia Intra, Nicole Rotmensz, Giuseppe Viale, and Umberto Veronesi
J Natl Cancer Inst 2004 96: 1110-1111.[Extract] [Full Text] [PDF]
- Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
- Peter C. Gøtzsche
J Natl Cancer Inst 2004 96: 1257.[Extract] [Full Text] [PDF]
- Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
- Helen Zorbas, Karen Luxford, Alison Evans, and Elmer V. Villanueva
J Natl Cancer Inst 2004 96: 1258.[Extract] [Full Text] [PDF]
- Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
- Gordon F. Schwartz, Michael D. Lagios, and Melvin J. Silverstein
J Natl Cancer Inst 2004 96: 1258-1259.[Extract] [Full Text] [PDF]
- RESPONSE: Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
- Nancy N. Baxter
J Natl Cancer Inst 2004 96: 1259-1260.[Extract] [Full Text] [PDF]
Editorial about this Article
- The Certainties and the Uncertainties of Ductal Carcinoma In Situ
- Monica Morrow
J Natl Cancer Inst 2004 96: 424-425.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  L. L. Hughes, M. Wang, D. L. Page, R. Gray, L. J. Solin, N. E. Davidson, M. A. Lowen, J. N. Ingle, A. Recht, and W. C. Wood Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group J. Clin. Oncol., November 10, 2009; 27(32): 5319 - 5324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Nekhlyudov, L. A. Habel, N. S. Achacoso, I. Jung, R. Haque, L. C. Collins, S. J. Schnitt, C. P. Quesenberry Jr, and S. W. Fletcher Adherence to Long-Term Surveillance Mammography Among Women With Ductal Carcinoma In Situ Treated With Breast-Conserving Surgery J. Clin. Oncol., July 1, 2009; 27(19): 3211 - 3216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Eheman, K. M. Shaw, A. B. Ryerson, J. W. Miller, U. A. Ajani, and M. C. White The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004 Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1763 - 1769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Tuttle, S. Jarosek, E. B. Habermann, A. Arrington, A. Abraham, T. J. Morris, and B. A. Virnig Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In Situ J. Clin. Oncol., March 20, 2009; 27(9): 1362 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rakovitch, J.-P. Pignol, W. Hanna, S. Narod, J. Spayne, S. Nofech-Mozes, C. Chartier, and L. Paszat Significance of Multifocality in Ductal Carcinoma In Situ: Outcomes of Women Treated With Breast-Conserving Therapy J. Clin. Oncol., December 10, 2007; 25(35): 5591 - 5596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Boughey, R. J. Gonzalez, E. Bonner, and H. M. Kuerer Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast Oncologist, November 1, 2007; 12(11): 1276 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Katz and S. T. Hawley From Policy To Patients And Back: Surgical Treatment Decision Making For Patients With Breast Cancer Health Aff., May 1, 2007; 26(3): 761 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Qaseem, V. Snow, K. Sherif, M. Aronson, K. B. Weiss, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 511 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Armstrong, E. Moye, S. Williams, J. A. Berlin, and E. E. Reynolds Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 516 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Latosinsky, K. Fradette, L. Lix, K. Hildebrand, and D. Turner Canadian breast cancer guidelines: Have they made a difference? Can. Med. Assoc. J., March 13, 2007; 176(6): 771 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Govindarajan, N. G. Coburn, A. Kiss, L. Rabeneck, A. J. Smith, and C. H. L. Law Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst, October 18, 2006; 98(20): 1474 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. I.J. Wildschut, T.J. Peters, and C. P. Weiner Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis Hum. Reprod. Update, September 1, 2006; 12(5): 499 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Punglia, J. C. Weeks, B. A. Neville, and C. C. Earle Radiation Therapy After Mastectomy Between 1991 and 1999 in Elderly Women: Response to Clinical Trial Information J. Clin. Oncol., July 20, 2006; 24(21): 3474 - 3482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Nekhlyudov, C. H. Kroenke, I. Jung, M. D. Holmes, and G. A. Colditz Prospective Changes in Quality of Life After Ductal Carcinoma-in-Situ: Results From the Nurses' Health Study J. Clin. Oncol., June 20, 2006; 24(18): 2822 - 2827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Buchholz, R. L. Theriault, J. C. Niland, M. E. Hughes, R. Ottesen, S. B. Edge, M. A. Bookman, and J. C. Weeks The Use of Radiation As a Component of Breast Conservation Therapy in National Comprehensive Cancer Network Centers J. Clin. Oncol., January 20, 2006; 24(3): 361 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Arpino, R. Laucirica, and R. M. Elledge Premalignant and In Situ Breast Disease: Biology and Clinical Implications Ann Intern Med, September 20, 2005; 143(6): 446 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Katz, P. M. Lantz, N. K. Janz, A. Fagerlin, K. Schwartz, L. Liu, D. Deapen, B. Salem, I. Lakhani, and M. Morrow Patient Involvement in Surgery Treatment Decisions for Breast Cancer J. Clin. Oncol., August 20, 2005; 23(24): 5526 - 5533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Katz, P. M. Lantz, N. K. Janz, A. Fagerlin, K. Schwartz, L. Liu, D. Deapen, B. Salem, I. Lakhani, and M. Morrow Patterns and Correlates of Local Therapy for Women With Ductal Carcinoma-In-Situ J. Clin. Oncol., May 1, 2005; 23(13): 3001 - 3007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Li, J. R. Daling, and K. E. Malone Age-Specific Incidence Rates of In situ Breast Carcinomas by Histologic Type, 1980 to 2001 Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 1008 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D D Gladman and A Menter Introduction/overview on clinical registries Ann Rheum Dis, March 1, 2005; 64(suppl_2): ii101 - ii102. [Full Text] [PDF]
|
|
|
|
|
|
D D Gladman, C Ritchlin, and P S Helliwell Psoriatic arthritis clinical registries and genomics Ann Rheum Dis, March 1, 2005; 64(suppl_2): ii103 - ii105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Gotzsche Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast J Natl Cancer Inst, August 18, 2004; 96(16): 1257 - 1257. [Full Text] [PDF]
|
|
|
|
|
|
H. Zorbas, K. Luxford, A. Evans, and E. V. Villanueva Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast J Natl Cancer Inst, August 18, 2004; 96(16): 1258 - 1258. [Full Text] [PDF]
|
|
|
|
|
|
G. F. Schwartz, M. D. Lagios, and M. J. Silverstein Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast J Natl Cancer Inst, August 18, 2004; 96(16): 1258 - 1259. [Full Text] [PDF]
|
|
|
|
|
|
M. Intra, N. Rotmensz, G. Viale, and U. Veronesi Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast J Natl Cancer Inst, July 21, 2004; 96(14): 1110 - 1111. [Full Text] [PDF]
|
|
|
|
|
|
G. D. Leonard and S. M. Swain Ductal Carcinoma In Situ, Complexities and Challenges J Natl Cancer Inst, June 16, 2004; 96(12): 906 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Gold and A. W. Dick Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast J Natl Cancer Inst, June 2, 2004; 96(11): 887 - 888. [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Tanne US study shows wide variation in approach to ductal carcinoma in situ BMJ, April 3, 2004; 328(7443): 785 - 785. [Full Text] [PDF]
|
|
|
|
|
|
M. Morrow The Certainties and the Uncertainties of Ductal Carcinoma In Situ J Natl Cancer Inst, March 17, 2004; 96(6): 424 - 425. [Full Text] [PDF]
|
|